1270014-40-8

SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). Because SNS-062 has demonstrated a distinct binding site and favorable pharmacokinetic profile in preclinical studies, SNS-062 may provide differentiated opportunities for treatment of B-cell malignancies and other blood cancers.